Status:

COMPLETED

Transcranial Electrical Stimulation (TES) for the Treatment of Depression.

Lead Sponsor:

The University of New South Wales

Conditions:

Major Depression

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study is a RCT of transcranial electrical stimulation in depressed patients. Mood, cognitive test performance and biomarkers will be measured during the trial.

Eligibility Criteria

Inclusion

  • DSM-IV Major Depressive Episode (as part of a Major Depressive Disorder or Bipolar Disorder), of minimum 4 weeks duration.
  • MADRS score ≥ 20 at study entry.

Exclusion

  • DSM-IV psychotic disorder;
  • drug or alcohol abuse or dependence (preceding 12 months);
  • inadequate response to ECT (current episode of depression);
  • anticonvulsant or benzodiazepine medication;
  • rapid clinical response required, e.g. high suicide risk; clinically defined neurological disorder or insult;
  • metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites;
  • pregnancy.

Key Trial Info

Start Date :

January 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2016

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT01792414

Start Date

January 1 2013

End Date

December 1 2016

Last Update

February 2 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Black Dog Institute / University of New South Wales

Sydney, New South Wales, Australia, 2031

Transcranial Electrical Stimulation (TES) for the Treatment of Depression. | DecenTrialz